These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35362378)

  • 1. Nurse-led and Interdisciplinary Secondary Cardiovascular Prevention Programmes: Spanish Cohort of the EUROACTION Project.
    Buigues C; Trapero I; Velasco JA; Salvador-Sanz A; Jennings C; Wood D; Queralt A
    Endocr Metab Immune Disord Drug Targets; 2022; 22(13):1319-1329. PubMed ID: 35362378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial.
    Wood DA; Kotseva K; Connolly S; Jennings C; Mead A; Jones J; Holden A; De Bacquer D; Collier T; De Backer G; Faergeman O;
    Lancet; 2008 Jun; 371(9629):1999-2012. PubMed ID: 18555911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Profile Results after Cardiovascular Prevention Programme: Euroaction Model in Spain.
    Buigues C; Queralt A; De Velasco JA; Salvador-Sanz A; Jennings C; Wood D; Trapero I
    Endocr Metab Immune Disord Drug Targets; 2020; 20(9):1412-1418. PubMed ID: 32520696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psycho-Social Factors in Patients with Cardiovascular Disease Attending a Family-Centred Prevention and Rehabilitation Programme: EUROACTION Model in Spain.
    Buigues C; Queralt A; De Velasco JA; Salvador-Sanz A; Jennings C; Wood D; Trapero I
    Life (Basel); 2021 Jan; 11(2):. PubMed ID: 33530575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial.
    Jennings C; Kotseva K; De Bacquer D; Hoes A; de Velasco J; Brusaferro S; Mead A; Jones J; Tonstad S; Wood D;
    Eur Heart J; 2014 Jun; 35(21):1411-20. PubMed ID: 24616337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal effects of a nurse-managed comprehensive cardiovascular disease prevention program for hospitalized coronary heart disease patients and primary care high-risk patients.
    Pająk A; Wolfshaut-Wolak R; Doryńska A; Jankowski P; Fornal M; Grodzicki T; Jennings C; Kawecka-Jaszcz K; Kotseva K; Pająk K; Wood D
    Kardiol Pol; 2020 May; 78(5):429-437. PubMed ID: 32238795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular risk reduction: impact of an international project].
    Colle B; Brusaferro S;
    Ann Ig; 2008; 20(3 Suppl 1):43-8. PubMed ID: 18773604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of treatment outcomes in patients with and without diabetes mellitus attending a multidisciplinary cardiovascular prevention programme (a retrospective analysis of the EUROACTION trial).
    Ofori SN; Kotseva K
    BMC Cardiovasc Disord; 2015 Feb; 15():11. PubMed ID: 25887559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translation of evidence-based guidelines in preventive cardiology: the EUROACTION program.
    Pearson TA;
    Nat Clin Pract Cardiovasc Med; 2009 Jan; 6(1):8-9. PubMed ID: 18941437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of a European preventive cardiology programme in primary care: a Markov modelling approach.
    Mistry H; Morris S; Dyer M; Kotseva K; Wood D; Buxton M;
    BMJ Open; 2012; 2(5):. PubMed ID: 23065443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a nurse-led eHealth cardiac rehabilitation programme on health outcomes of patients with coronary heart disease: A randomised controlled trial.
    Su JJ; Yu DS
    Int J Nurs Stud; 2021 Oct; 122():104040. PubMed ID: 34333211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of a cardiovascular disease primary prevention programme in a primary health care setting. Results of the Polish part of the EUROACTION project.
    Sović N; Pająk A; Jankowski P; Duenas A; Kawecka-Jaszcz K; Wolfshaut-Wolak R; Stepaniak U; Kawalec P
    Kardiol Pol; 2013; 71(7):702-11. PubMed ID: 23907903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
    Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
    Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of Hartcoach, a life style intervention provided by telephone on the reduction of coronary risk factors: a randomised trial.
    Leemrijse CJ; van Dijk L; Jørstad HT; Peters RJ; Veenhof C
    BMC Cardiovasc Disord; 2012 Jun; 12():47. PubMed ID: 22734802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced motivational interviewing for reducing weight and increasing physical activity in adults with high cardiovascular risk: the MOVE IT three-arm RCT.
    Ismail K; Stahl D; Bayley A; Twist K; Stewart K; Ridge K; Britneff E; Ashworth M; de Zoysa N; Rundle J; Cook D; Whincup P; Treasure J; McCrone P; Greenough A; Winkley K
    Health Technol Assess; 2019 Dec; 23(69):1-144. PubMed ID: 31858966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of a nurse-led lifestyle intervention program on cardiovascular risk, self-efficacy and health promoting behaviours among patients with metabolic syndrome: Randomized controlled trial.
    Zheng X; Yu H; Qiu X; Chair SY; Wong EM; Wang Q
    Int J Nurs Stud; 2020 Sep; 109():103638. PubMed ID: 32553996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a nurse-led lipid-lowering secondary prevention intervention in patients hospitalized for ischemic heart disease: A pilot randomized controlled trial.
    Ruiz-Bustillo S; Ivern C; Badosa N; Farre N; Marco E; Bruguera J; Cladellas M; Enjuanes C; Cainzos-Achirica M; Marti-Almor J; Comin-Colet J
    Eur J Cardiovasc Nurs; 2019 Jun; 18(5):366-374. PubMed ID: 30757908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of team-based collaborative care for distressed patients in secondary prevention of chronic coronary heart disease (TEACH): study protocol of a multicenter randomized controlled trial.
    Herrmann-Lingen C; Albus C; de Zwaan M; Geiser F; Heinemann K; Hellmich M; Michal M; Sadlonova M; Tostmann R; Wachter R; Herbeck Belnap B
    BMC Cardiovasc Disord; 2020 Dec; 20(1):520. PubMed ID: 33302871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial.
    Ho PM; Lambert-Kerzner A; Carey EP; Fahdi IE; Bryson CL; Melnyk SD; Bosworth HB; Radcliff T; Davis R; Mun H; Weaver J; Barnett C; Barón A; Del Giacco EJ
    JAMA Intern Med; 2014 Feb; 174(2):186-93. PubMed ID: 24247275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.